Chronic myeloid leukemia (CML) arises when the BCR–ABL1 fusion oncogene forms and is activated in hematopoietic stem cells (HSCs) [1,2]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.